BMC Cancer (Jul 2024)

Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach

  • Ash Bullement,
  • Mark Edmondson-Jones,
  • Nicholas Latimer

DOI
https://doi.org/10.1186/s12885-024-12287-6
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 3

Abstract

Read online

No abstracts available.

Keywords